supported by new onset rash, increasing vasopressor requirement and rapid shock reversal after adrenaline and lastly raised total IgE also. Subsequently, soybean allergy was confi rmed by history and skin test. According to Naranjo probability scale method of adverse drug reaction, this case is possible type (Naranjo total score >8). [3] Propofol (having same composition of ILE) causes anaphylaxis due to its egg and soybean components. [1, 2] In a case of propofol induced anaphylaxis, patient showed immediate reaction to skin prick with 20% intralipid also. [1] Anaphylaxis following ingestion of generic drug (omeprazole) containing soybean oil is reported. [4] Fever with hypotension (increasing vasopressor requirement) in an ICU setting of ongoing septic shock mostly indicates a new onset sepsis and septic shock or worsening of existing septic shock. [5] Anaphylactic shock often mimics septic shock by decrease in systemic vascular resistance. [5] Especially, if both shock co-exists in a patient, it is very diffi cult to differentiate.
Through our report, our clear message is before starting ILE one has to ask history of soybean and egg allergy and intradermal test is to be done before starting infusion.
Raised immunoglobulin E levels are not Raised immunoglobulin E levels are not predictive of allergic reactions to blood products predictive of allergic reactions to blood products Sir,
The report by Shanthi et al. on an acute allergic reaction after platelet transfusion in the patient with cerebral malaria needs clarifi cation on a few points. [1] The authors suggest that this was an immunoglobulin G and E (IgG and IgE)-mediated reaction although the reasons behind this conclusion were not justifi ed.
The gel column tube merely shows an indirect antibody test against complement coated red cells, and not a specially designed column to detect IgG against platelets. Secondly, raised IgE levels after transfusion does not indicate an IgE-mediated event and the authors have not provided the IgE levels before the transfusion. The authors acknowledge that IgE levels are known to be raised in cerebral malaria, but continue to state the confusing conclusion.
A raised IgE level on its own, even in the absence of parasite infestation is generally not considered a risk factor for transfusion of blood products, but atopic predisposition may be a (non-specifi c) risk factor. [2] However, there is currently no data to suggest that an IgE cut-off value can be used to confer this risk to recipients of any blood product, including apheresis platelets. Certain donorrelated mechanisms may explain IgE-mediated reactions, such as donor food-specifi c IgE antibodies causing reactions after recipient eats the culprit food, or blood components with penicillin-specifi c IgE that lead to severe allergic reaction when the recipient is treated with penicillin. The role of direct allergic agonists such as complement 5a and others appears more plausible in this regard. [3] Pre-treatment with antihistaminics and acetaminophen may prevent febrile non-hemolytic transfusion reactions but not severe allergic reactions. [4] The only test that can be helpful in the setting of suspected anaphylaxis to blood products is mast cell tryptase that should be done either at 1 h or between 2 and 4 h and a defi nite sample at 24 h post-event (when levels should have returned to baseline). Unless specifi c trials demonstrate the safety and effi cacy of anti-IgE monoclonal antibody therapy in preventing transfusion reactions to blood products, lowering the total IgE level may not have any clinical signifi cance and will simply lead to a signifi cant increase in treatment costs.
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Diagnostic dilemmas in human Diagnostic dilemmas in human immunodefi ciency virus testing immunodefi ciency virus testing
Sir, Screening for human immunodefi ciency virus (HIV) in India is performed using serological assays as per guidelines laid down by the National AIDS Control Organization (NACO). [1] False-positive serological results are known to occur in various diseases or situations. [2, 3] We report a case of false-positive HIV serology in a patient with chronic liver disease (CLD). The patient was diagnosed as a case of autoimmune hepatitis (AIH) in whom initial serological screening assays were reactive, while confi rmatory testing, that is, HIV western blot and HIV-1 RNA real time reverse transcriptase polymerase chain reaction (RT-PCR) were both negative.
The patient, a 64-year-old woman (a housewife), was admitted to our institute on 17 th October 2010 for the evaluation of abnormal liver function tests (LFTs). She was a known case of type 2 diabetes mellitus since 10 years. She gave history of vomiting of blood on two occasions in the last 3 months. Physical examination revealed hepatomegaly, splenomegaly, ascites, fi nger clubbing, and palmar erythema. LFTs revealed serum bilirubin: 1.56 mg% (direct fraction 0.4%), alanine aminotransferase: 17 IU/L, aspartate aminotransferase: 20 IU/L, and serum proteins: 7.3 gm% (albumin 1.7, globulin 5.6). Serological markers for hepatitis B, C, A, and E viruses were nonreactive.
A requisition for HIV serology was received at the virology laboratory. Her sample was tested according to NACO Strategy/ Algorithm III [1] and the following kits were used: R1: 4 th generation ELISA ULTRA HIV Ag-Ab kit (BioRad Genetic sys, France) (sensitivity 100%, specifi city 99.1%), R2: HIV Tri-Dot assay (J. Mitra Ltd, India) (sensitivity 100%, specifi city 100%), R3: SD Bioline HIV1/2 3.0 (SD Biostandard Diagnostics Pvt. Ltd, India). The results were R1+, R2+, and R3+.
Since the patient was asymptomatic with no relevant history suggestive for high risk group, confi rmatory testing was performed.
The sample was fi rst tested for antibodies to HIV-1 by western blot (immunoblot assay) (New LAV Blot-1 Assay, Bio-Rad laboratories, Inc.) and was nonreactive for the same. The sample was also tested for HIV-1 RNA by real time RT-PCR (Cobas Taqman HIV-1 test, Roche Molecular Systems Inc, Branchburg, NJ, USA) and no HIV-1 RNA was detected by the same. A negative report for HIV was generated.
After ruling out viral causes for hepatitis, investigations for AIH were performed [ Table 1 ]. Investigations also revealed hypergammaglobulinemia with serum IgG-30.1 g/L (Normal range 7-16 g/L). Based on the above results, she was diagnosed with CLD with decompensated cirrhosis due to AIH type 1.
False-positive results with enzyme immunoassays are known to occur in many diseases/situations. Important conditions include multiple blood transfusions, hypergammaglobulinemia, history of recent vaccination, multiple pregnancies, hemodialysis, antibodies to HLA antigens, autoantibodies associated with autoimmune diseases, and cross-reactivity with vector proteins, etc. [2, 4] Our patient was diagnosed as a case of AIH type 1 with hypergammaglobulinemia, both conditions being known causes of false-positive serology with HIV assays. [5] [6] [7] NACO Strategy/Algorithm III is applicable to patients who are asymptomatic and have no AIDS indicator disease symptoms. It requires three assays to be performed for HIV testing. The patient was reactive by all three screening assays (R1+, R2+, R3+). However, confi rmatory tests turned out to be negative. Thus, this case is one of cross-reactive antibodies with HIV. 
